LPGAT1 Activators
The term LPGAT1 Activators refers to a specific category of chemical compounds designed to modulate the activity of the LPGAT1 enzyme. LPGAT1, or Lysophosphatidylglycerol acyltransferase 1, is an enzyme that plays a vital role in lipid metabolism and membrane biogenesis. Its primary function is to catalyze the transfer of an acyl group from acyl-coenzyme A to lysophosphatidylglycerol (LPG), ultimately leading to the synthesis of phosphatidylglycerol (PG), a key component of cellular membranes. Activators within the LPGAT1 Activators class are typically small molecules or chemical agents strategically engineered to interact with the LPGAT1 enzyme, with the objective of enhancing its enzymatic activity or influencing its regulatory mechanisms. These activators serve as valuable tools for researchers to manipulate LPGAT1-related processes in various biological contexts, with a focus on elucidating its role in lipid homeostasis and membrane dynamics.
The mechanism of action for LPGAT1 Activators can encompass different levels of enzyme regulation. These compounds may influence the binding of substrates or cofactors to LPGAT1, potentially promoting the catalytic efficiency of the enzyme. Alternatively, they could affect post-translational modifications of LPGAT1, such as phosphorylation or protein-protein interactions, which can modulate its activity and subcellular localization. Researchers and scientists utilize LPGAT1 Activators in molecular biology and lipid metabolism studies to investigate the intricate mechanisms by which LPGAT1 contributes to membrane biogenesis and lipid homeostasis. By selectively modulating the enzyme's activity, researchers can gain insights into its functions, regulatory mechanisms, and potential implications in cellular membrane composition and integrity, thus enhancing our understanding of the molecular processes involving LPGAT1 and its role in cellular physiology. Overall, LPGAT1 Activators provide essential tools for exploring the functions and regulatory mechanisms of LPGAT1 and its significance in lipid metabolism and membrane biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, involved in cell differentiation and metabolism, might influence LPGAT1 expression as part of its regulatory effects on lipid metabolism and mitochondrial function. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As PPARγ agonists, thiazolidinediones regulate lipid metabolism and adipogenesis, potentially upregulating LPGAT1 in tissues involved in lipid storage and metabolism. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fibrates, as PPARα agonists, influence fatty acid oxidation and lipid metabolism, potentially affecting LPGAT1 expression in the liver and other metabolically active tissues. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Omega-3 fatty acids can modulate lipid metabolism and inflammatory responses, potentially upregulating LPGAT1 as part of their effect on membrane lipid composition. | ||||||
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $53.00 $91.00 $169.00 $474.00 | 8 | |
As an oxysterol, 25-hydroxycholesterol regulates lipid metabolism and immune responses, potentially influencing LPGAT1 expression in the context of sterol homeostasis. | ||||||
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $114.00 $286.00 | 2 | |
Palmitic acid, a saturated fatty acid, might influence LPGAT1 expression due to its role in lipid biosynthesis and metabolism, particularly under conditions of high fatty acid flux. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
AMPK activation affects cellular energy balance and can influence lipid metabolism pathways, potentially upregulating LPGAT1 as part of the adaptive response to energetic stress. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibition of mTOR signaling affects cell growth and metabolism, potentially influencing LPGAT1 expression as part of the cellular response to altered growth conditions. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoids affect lipid metabolism and inflammatory responses, potentially modulating LPGAT1 expression in the context of stress and metabolic regulation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin regulates glucose and lipid metabolism, potentially influencing LPGAT1 expression as part of its role in lipid synthesis and storage in insulin-responsive tissues. | ||||||